Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neurofibromatosis
ADR ID BADD_A03042
ADR Hierarchy
03      Congenital, familial and genetic disorders
03.10      Neurological disorders congenital
03.10.01      Neurological disorders congenital NEC
03.10.01.002      Neurofibromatosis
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.09      Nervous system neoplasms benign
16.09.01      Nervous system neoplasms benign NEC
16.09.01.002      Neurofibromatosis
17      Nervous system disorders
17.18      Nervous system neoplasms benign
17.18.01      Nervous system neoplasms benign NEC
17.18.01.002      Neurofibromatosis
Description A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72) [MeSH]
MedDRA Code 10029268
MeSH ID D017253
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neurofibromatosis | Neurofibromatosis aggravated | Neurofibromatosis, type 1 (von Recklinghausen's disease) | Neurofibromatosis, type 2 (acoustic neurofibromatosis) | Neurofibromatosis, unspecified | Von Recklinghausen's disease (of nerve) | Neurofibromatoses | Neurofibromatosis Syndrome | Neurofibromatosis Syndromes | Syndrome, Neurofibromatosis | Syndromes, Neurofibromatosis | Multiple Neurofibromas | Multiple Neurofibroma | Neurofibroma, Multiple | Neurofibromas, Multiple | Neurofibromatosis 3 | Neurofibromatosis 3s | Neurofibromatosis Type 3 | Neurofibromatosis Type 3s | Type 3, Neurofibromatosis
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D01136Imatinib0.000139%
BADD_D01265Levetiracetam0.000099%
BADD_D01281Levonorgestrel0.000544%
The 1th Page    1    Total 1 Pages